Sungbin Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sungbin Choi has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ok-Nam Bae
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea
7 shared publications - Hanjin Park
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea
4 shared publications Eun-Hye Kim
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea; College of Pharmacy, Kyungsung University, Busan 48434, Republic of Korea
3 shared publicationsDonghyun Kim
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan 15588, Republic of Korea; College of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea
2 shared publications- Donghyun Kim
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University ERICA Campus, Ansan, South Korea
2 shared publications - Han Young Chung
College of Pharmacy, Chungnam National University, Daejeon 34134, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 6 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (6) , eady8284
RTX-family toxin EhxA drives morphological remodeling and thrombogenesis in RBCs during enterohemorrhagic Escherichia coli infection
Enterohemorrhagic Escherichia coli (EHEC) causes thrombotic microangiopathy, yet the red blood cell (RBC)–centered mechanism has remained unclear. We identify the RTX-family hemolysin EhxA as the driver of RBC-mediated thrombogenesis. Deletion of ehxA abolishes Ca 2+ influx, phosphatidylserine (PS) exposure, progression from discocyte to echinocyte to spherocyte, thrombin generation, RBC-endothelium adhesion, and RBC aggregation. Genetic complementation restores these readouts to wild type, and purified EhxA in bacteria-free assays recapitulates them while localizing to intact RBC membranes. By contrast, Δ stx2 mutants do not elicit these RBC phenotypes, distinguishing this pathway from Shiga toxin–dependent effects. Multiple regression quantifies the link between PS exposure, morphology, and procoagulant outputs. In rats, infection with wild type increased RBC remodeling and venous thrombosis, whereas infection with Δ ehxA did not. Together, the data define an EhxA-Ca 2+ -PS pathway that drives RBC structural remodeling and procoagulant activation during EHEC infection and nominate RTX toxins as targets for preventing toxin-induced coagulopathies.
- 6 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (6) , eady8284
Open AccessRTX-family toxin EhxA drives morphological remodeling and thrombogenesis in RBCs during enterohemorrhagic Escherichia coli infection
Enterohemorrhagic Escherichia coli (EHEC) causes thrombotic microangiopathy, yet the red blood cell (RBC)–centered mechanism has remained unclear. We identify the RTX-family hemolysin EhxA as the driver of RBC-mediated thrombogenesis. Deletion of ehxA abolishes Ca 2+ influx, phosphatidylserine (PS) exposure, progression from discocyte to echinocyte to spherocyte, thrombin generation, RBC-endothelium adhesion, and RBC aggregation. Genetic complementation restores these readouts to wild type, and purified EhxA in bacteria-free assays recapitulates them while localizing to intact RBC membranes. By contrast, Δ stx2 mutants do not elicit these RBC phenotypes, distinguishing this pathway from Shiga toxin–dependent effects. Multiple regression quantifies the link between PS exposure, morphology, and procoagulant outputs. In rats, infection with wild type increased RBC remodeling and venous thrombosis, whereas infection with Δ ehxA did not. Together, the data define an EhxA-Ca 2+ -PS pathway that drives RBC structural remodeling and procoagulant activation during EHEC infection and nominate RTX toxins as targets for preventing toxin-induced coagulopathies.
- Open Access
- 29 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11606
Red Blood Cell-Associated Features of Adenoviral Vector-Linked Venous Thrombosis
Adenoviral vector vaccines were pivotal for COVID-19 control, but postmarketing safety surveillance has identified venous-predominant thrombotic risks not fully explained by platelet-centric mechanisms. We tested an RBC-associated hypothesis using an Ad5 vector-rAd/HA(PR8) rat model within a predefined sub-hemolytic window (8–109 OPU/Rat). In vivo, an inferior vena cava thrombosis model showed a pronounced, dose-responsive rise in thrombus burden, consistent with increased thrombogenic potential. Together, these integrated data provide experimental evidence consistent with RBC involvement under adenoviral exposure, supporting a biologically plausible link to the venous-predominant epidemiology observed during the COVID-19 vaccination era. Reported clinical adenoviral vaccine doses are of the same order of magnitude as the exposures tested here, supporting translational relevance while not implying inter-species or product equivalence. Incorporating RBC-focused endpoints, including PS exposure, morphology indices, microvesicle counts, and thrombin generation, into preclinical and early clinical assessments may enhance safety evaluation and inform vector design to mitigate venous thrombotic risk.
- 29 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11606
Open AccessRed Blood Cell-Associated Features of Adenoviral Vector-Linked Venous Thrombosis
Adenoviral vector vaccines were pivotal for COVID-19 control, but postmarketing safety surveillance has identified venous-predominant thrombotic risks not fully explained by platelet-centric mechanisms. We tested an RBC-associated hypothesis using an Ad5 vector-rAd/HA(PR8) rat model within a predefined sub-hemolytic window (8–109 OPU/Rat). In vivo, an inferior vena cava thrombosis model showed a pronounced, dose-responsive rise in thrombus burden, consistent with increased thrombogenic potential. Together, these integrated data provide experimental evidence consistent with RBC involvement under adenoviral exposure, supporting a biologically plausible link to the venous-predominant epidemiology observed during the COVID-19 vaccination era. Reported clinical adenoviral vaccine doses are of the same order of magnitude as the exposures tested here, supporting translational relevance while not implying inter-species or product equivalence. Incorporating RBC-focused endpoints, including PS exposure, morphology indices, microvesicle counts, and thrombin generation, into preclinical and early clinical assessments may enhance safety evaluation and inform vector design to mitigate venous thrombotic risk.
- Open Access
- 15 September 2025
- Published by The Korean Society of Environmental Health and Toxicology in Environmental Analysis Health and Toxicology
- Vol. 40 (Special ) , e2025s08
Quantitative neurotoxic effects of heavy metals and glutamate in mouse hippocampal neuronal cells
Exposure to toxic heavy metals, such as lead, mercury, arsenic, and cadmium (Pb²⁺, Hg²⁺, As⁵⁺, As³⁺, and Cd²⁺), is a known contributor to neurological dysfunction. Although the individual neurotoxicity of these metals has been well established, their synergistic effects with endogenous neurotoxins such as glutamate remain insufficiently explored. In this study, we investigated neurotoxic effects of the combination of glutamate and heavy metals using the HT-22 hippocampal neuronal cell line. The cells were exposed to each heavy metal alone or in combination with glutamate at low [LCR; glutamate: heavy metal = 1:0.0025] and high [HCR; glutamate: heavy metal = 1:0.025] concentration ratios. Cell viability was measured by the MTT assay, and synergistic effects were quantitatively assessed by the Chou–Talalay method using CompuSyn software. The results showed that Pb²⁺ exhibited consistent synergistic effects with glutamate at both concentration ratios. In addition, Hg²⁺ and As⁵⁺ demonstrated synergistic effects with glutamate under high concentration conditions. These findings highlight that certain heavy metals can potentiate glutamate-induced neurotoxicity through synergistic mechanisms. This study provides quantitative evidence for the enhanced neurotoxic potential of environmental heavy metals when combined with endogenous excitotoxins such as glutamate.
- 15 September 2025
- Published by The Korean Society of Environmental Health and Toxicology in Environmental Analysis Health and Toxicology
- Vol. 40 (Special ) , e2025s08
Open AccessQuantitative neurotoxic effects of heavy metals and glutamate in mouse hippocampal neuronal cells
Exposure to toxic heavy metals, such as lead, mercury, arsenic, and cadmium (Pb²⁺, Hg²⁺, As⁵⁺, As³⁺, and Cd²⁺), is a known contributor to neurological dysfunction. Although the individual neurotoxicity of these metals has been well established, their synergistic effects with endogenous neurotoxins such as glutamate remain insufficiently explored. In this study, we investigated neurotoxic effects of the combination of glutamate and heavy metals using the HT-22 hippocampal neuronal cell line. The cells were exposed to each heavy metal alone or in combination with glutamate at low [LCR; glutamate: heavy metal = 1:0.0025] and high [HCR; glutamate: heavy metal = 1:0.025] concentration ratios. Cell viability was measured by the MTT assay, and synergistic effects were quantitatively assessed by the Chou–Talalay method using CompuSyn software. The results showed that Pb²⁺ exhibited consistent synergistic effects with glutamate at both concentration ratios. In addition, Hg²⁺ and As⁵⁺ demonstrated synergistic effects with glutamate under high concentration conditions. These findings highlight that certain heavy metals can potentiate glutamate-induced neurotoxicity through synergistic mechanisms. This study provides quantitative evidence for the enhanced neurotoxic potential of environmental heavy metals when combined with endogenous excitotoxins such as glutamate.
- 20 January 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 495, 117233
Cadmium-induced iron dysregulation contributes to functional impairment in brain endothelial cells via the ferroptosis pathway
- 20 January 2025
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 495, 117233
Cadmium-induced iron dysregulation contributes to functional impairment in brain endothelial cells via the ferroptosis pathway
- 10 September 2024
- Published by Elsevier in Environmental Pollution
- Vol. 362, 124921
Promoted coagulant activity and disrupted blood-brain barrier depending on phosphatidylserine externalization of red blood cells exposed to ZnO nanoparticles
- 10 September 2024
- Published by Elsevier in Environmental Pollution
- Vol. 362, 124921
Promoted coagulant activity and disrupted blood-brain barrier depending on phosphatidylserine externalization of red blood cells exposed to ZnO nanoparticles